Nancy Lurker - Net Worth and Insider Trading

Nancy Lurker Net Worth

The estimated net worth of Nancy Lurker is at least $4 Million dollars as of 2024-05-04. Nancy Lurker is the Executive Vice Chair of EyePoint Pharmaceuticals Inc and owns about 187,649 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $4 Million. Details can be seen in Nancy Lurker's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nancy Lurker has not made any transactions after 2024-01-24 and currently still holds the listed stock(s).

Transaction Summary of Nancy Lurker

To

Nancy Lurker Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nancy Lurker owns 5 companies in total, including EyePoint Pharmaceuticals Inc (EYPT) , Aquestive Therapeutics Inc (AQST) , and Mallinckrodt PLC (MNKKQ) among others .

Click here to see the complete history of Nancy Lurker’s form 4 insider trades.

Insider Ownership Summary of Nancy Lurker

Ticker Comapny Transaction Date Type of Owner
EYPT EyePoint Pharmaceuticals Inc 2024-01-24 director & President and CEO
AQST Aquestive Therapeutics Inc 2018-07-24 director
MNKKQ Mallinckrodt PLC 2013-06-28 director
2008-11-18 CEO
2013-06-28 director

Nancy Lurker Latest Holdings Summary

Nancy Lurker currently owns a total of 1 stock. Nancy Lurker owns 187,649 shares of EyePoint Pharmaceuticals Inc (EYPT) as of January 24, 2024, with a value of $4 Million.

Latest Holdings of Nancy Lurker

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EYPT EyePoint Pharmaceuticals Inc 2024-01-24 187,649 19.74 3,704,191

Holding Weightings of Nancy Lurker


Nancy Lurker Form 4 Trading Tracker

According to the SEC Form 4 filings, Nancy Lurker has made a total of 4 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in EyePoint Pharmaceuticals Inc is the sale of 35,000 shares on January 24, 2024, which brought Nancy Lurker around $874,300.

Insider Trading History of Nancy Lurker

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nancy Lurker Trading Performance

GuruFocus tracks the stock performance after each of Nancy Lurker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nancy Lurker is -18%. GuruFocus also compares Nancy Lurker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nancy Lurker within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nancy Lurker's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nancy Lurker

Average Return

Average return per transaction

Outperforming Transactions

1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.82
Relative Return to S&P 500(%) -12.32

Nancy Lurker Ownership Network

Ownership Network List of Nancy Lurker

No Data

Ownership Network Relation of Nancy Lurker


Nancy Lurker Owned Company Details

What does EyePoint Pharmaceuticals Inc do?

Who are the key executives at EyePoint Pharmaceuticals Inc?

Nancy Lurker is the director & President and CEO of EyePoint Pharmaceuticals Inc. Other key executives at EyePoint Pharmaceuticals Inc include SVP & Chief Commercial Officer David Scott Jones , Chief Medical Officer Dario A. Paggiarino , and Chief Corp Dev.&Strat. Officer Michael Craig Pine .

EyePoint Pharmaceuticals Inc (EYPT) Insider Trades Summary

Over the past 18 months, Nancy Lurker made 2 insider transaction in EyePoint Pharmaceuticals Inc (EYPT) with a net sale of 55,000. Other recent insider transactions involving EyePoint Pharmaceuticals Inc (EYPT) include a net sale of 943,936 shares made by Ew Healthcare Partners, L.p. , a net sale of 121,307 shares made by Dario A. Paggiarino , and a net purchase of 3,944,057 shares made by Cormorant Asset Management, Lp .

In summary, during the past 3 months, insiders sold 0 shares of EyePoint Pharmaceuticals Inc (EYPT) in total and bought 581,765 shares, with a net purchase of 581,765 shares. During the past 18 months, 4,194,936 shares of EyePoint Pharmaceuticals Inc (EYPT) were sold and 3,944,057 shares were bought by its insiders, resulting in a net sale of 250,879 shares.

EyePoint Pharmaceuticals Inc (EYPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

EyePoint Pharmaceuticals Inc Insider Transactions

No Available Data

Nancy Lurker Mailing Address

Above is the net worth, insider trading, and ownership report for Nancy Lurker. You might contact Nancy Lurker via mailing address: Pdi, Inc., 1 Route 17 South, Saddle River Nj 07458.

Discussions on Nancy Lurker

No discussions yet.